Response to the Letter to the Editor Entitled “Critical Reappraisal of Obinutuzumab Randomized Trials in Membranous Nephropathy”

By afschroeder • August 2, 2026

Giri K, Glassock RJ, Fervenza FC. Response to the Letter to the Editor Entitled "Critical Reappraisal of Obinutuzumab Randomized Trials in Membranous Nephropathy". Kidney Int Rep. 2026 Jun 6;11(9):106658. doi: 10.1016/j.ekir.2026.106658. PMID: 42541134; PMCID: PMC13427534.

Tags: Emeritus, Harbor UCLA, Nephrology, Publications

Association of Estimated GFR at the Time of Peritoneal Dialysis Catheter Insertion With Dialysis-Related Complications

Dhoot A, Quinn RR, Clarke A, Armstrong S, Burdick R, Jain AK, Jassal SV, Kennealey PT, Liebman S, McCormick BB, Momciu B, Pauly RP, Perl[...]

Murine Typhus Masquerading as Thrombotic Thrombocytopenic Purpura in a Patient With Newly Diagnosed HIV

Abdul Cader J, Lee SM, Tsai A. Murine Typhus Masquerading as Thrombotic Thrombocytopenic Purpura in a Patient With Newly Diagnosed HIV. Cureus. 2026 Sep 21;18(9):e116679.[...]

Belimumab With Rituximab for the Treatment of Primary Membranous Nephropathy

Chung SA, Stelzig L, Sherman MA, Gao W, Tosta P, Cooney LA, Adler S, Aslam N, Ayoub I, Bomback AS, Coppock G, Derebail VK, Kamal[...]